4
Changes in Ownership
Vericel Corp Filed Acc 0001179110-12-007889
Options or other derivatives
- VP Clinical Development acquired 117,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Watling Sharon VP Clinical Development | 2012-05-03 | Grant or award · Stock Option (right to buy) | +117,000 | $2.49 | $291,330 | 117,000 | D |
Loading xslF345X03/edgar.xml…